33 results on '"Aune, Dagfinn"'
Search Results
2. Association between health literacy and Framingham risk score
- Author
-
Rahimi, Tahereh, primary, Hashemi, Seyedeh Soroor, additional, Rezaei, Fatemeh, additional, and Aune, Dagfinn, additional
- Published
- 2024
- Full Text
- View/download PDF
3. Office-based risk equation of Globorisk for prediction of ten-years cardiovascular risk among Iranian population: findings from Fasa PERSIAN cohort study.
- Author
-
Baseri, Amir, Dehghan, Azizallah, Khezri, Rozhan, Montaseri, Zahra, Aune, Dagfinn, and Rezaei, Fatemeh
- Abstract
Background: Globorisk is one of the prediction tools for 10-year risk assessment of cardiovascular disease, featuring an office-based (non-laboratory-based) version. This version does not require laboratory tests for determining the CVD risk. The present study aims to determine the 10-year CVD risk using the office-based Globorisk model and factors associated with the 10-year CVD risk. Methods: In this study, baseline data from 6810 individuals participating in the Fasa cohort study, with no history of CVD or stroke, were utilized. The risk equation of the office-based Globorisk model incorporates age, sex, systolic blood pressure (SBP), body mass index (BMI), and smoking status. The Globorisk model categorizes the risk into three groups: low risk (< 10%), moderate risk (10% to < 20%), and high risk (≥ 20%). To identify factors associated with the 10-year CVD risk, the predicted risk was categorized into two groups: <10% and ≥ 10%. Multivariable logistic regression analysis was employed to determine factors associated with an increased CVD risk. Results: According to the 10-year CVD risk categorization, 78.3%, 16.4%, and 5.3% of men were in the low, moderate, and high risk groups, respectively, while 85.8%, 10.0%, and 4.2%, of women were in the respective risk groups. Multivariable logistic regression results indicated that in men, the 10-year CVD risk decreases with being an opium user, and increases with being illiterate, having abdominal obesity, and low or moderate physical activity compared to high physical activity. In women, being married, and higher fiber consumption decrease the 10-year CVD risk, while being illiterate, low or moderate physical activity compared to high physical activity, having abdominal obesity, opium use, and being in wealth quintiles 1 to 4 compared to quintile 5 increase the risk. Conclusions: Considering the factors associated with increased CVD risk, there is a need to enhance awareness and modify lifestyle to mitigate and reduce the risk of CVD. Additionally, early identification of individuals at moderate to high risk is essential for preventing disease progression. The use of the office-based Globorisk model can be beneficial in settings where resources are limited for determining the 10-year CVD risk. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Dispensed prescription medications and short-term risk of pulmonary embolism in Norway and Sweden.
- Author
-
Aune, Dagfinn, Vardaxis, Ioannis, Lindqvist, Bo Henry, Brumpton, Ben Michael, Strand, Linn Beate, Horn, Jens Wilhelm, Bakken, Inger Johanne, Romundstad, Pål Richard, Mukamal, Kenneth J., Ljung, Rickard, Janszky, Imre, and Sen, Abhijit
- Subjects
- *
FUROSEMIDE , *OPIOID analgesics , *PULMONARY embolism , *DRUG side effects , *ANGIOTENSIN-receptor blockers - Abstract
Scandinavian electronic health-care registers provide a unique setting to investigate potential unidentified side effects of drugs. We analysed the association between prescription drugs dispensed in Norway and Sweden and the short-term risk of developing pulmonary embolism. A total of 12,104 pulmonary embolism cases were identified from patient- and cause-of-death registries in Norway (2004–2014) and 36,088 in Sweden (2005–2014). A case-crossover design was used to compare individual drugs dispensed 1–30 days before the date of pulmonary embolism diagnosis with dispensation in a 61–90 day time-window, while controlling for the receipt of other drugs. A BOLASSO approach was used to select drugs that were associated with short-term risk of pulmonary embolism. Thirty-eight drugs were associated with pulmonary embolism in the combined analysis of the Norwegian and Swedish data. Drugs associated with increased risk of pulmonary embolism included certain proton-pump inhibitors, antibiotics, antithrombotics, vasodilators, furosemide, anti-varicose medications, corticosteroids, immunostimulants (pegfilgrastim), opioids, analgesics, anxiolytics, antidepressants, antiprotozoals, and drugs for cough and colds. Mineral supplements, hydrochlorothiazide and potassium-sparing agents, beta-blockers, angiotensin 2 receptor blockers, statins, and methotrexate were associated with lower risk. Most associations persisted, and several additional drugs were associated, with pulmonary embolism when using a longer time window of 90 days instead of 30 days. These results provide exploratory, pharmacopeia-wide evidence of medications that may increase or decrease the risk of pulmonary embolism. Some of these findings were expected based on the drugs' indications, while others are novel and require further study as potentially modifiable precipitants of pulmonary embolism. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Hypertension among persons with type 2 diabetes and its related demographic, socioeconomic and lifestyle factors in the Fasa cohort study.
- Author
-
Taheri, Ali, Khezri, Rozhan, Dehghan, Azizallah, Rezaeian, Mehdi, Aune, Dagfinn, and Rezaei, Fatemeh
- Subjects
TYPE 2 diabetes ,SOCIOECONOMIC factors ,HYPERTENSION risk factors ,PHYSICAL activity ,HYPERTENSION ,COHORT analysis - Abstract
Hypertension is a very common comorbidity in type 2 diabetes patients, which leads to important health and treatment challenges. The present study was conducted with the aim of determining the prevalence of hypertension and its risk factors in type 2 diabetes patients. This study was conducted using cross-sectional data from 1245 participants aged between 35 and 70 years and diagnosed with type 2 diabetes at baseline in the Fasa cohort study. The prevalence hypertension was determined and multivariate logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association between various risk factors and hypertension prevalence. The average age of the participants was 53.5 ± 8.7 years and 71.7% (n = 893) were female and 28.3% (n = 352) were male. The prevalence of hypertension in people with type 2 diabetes was 45.5% (n = 566). Higher age (AOR, 95% CI: 8.1, 4.6–14.3), female gender (OR, 95% CI: 1.8, 1.2–2.5), Fars (AOR, 95% CI: 1.6, 1.1–2.4) and Turk (AOR, 95% CI: 1.6, 1.1–2.5) vs. other ethnicity, and overweight (AOR, 95% CI: 1.8, 1.38–2.38) and obesity (AOR, 95% CI: 2.7, 2.0–3.8) vs. BMI < 25 was associated with a higher prevalence of hypertension, while higher physical activity (AOR, 95% CI: 0.57, 0.42–0.78) was associated with lower prevalence of hypertension in the multivariable model. The prevalence of hypertension in persons with type 2 diabetes was high and increased with greater age, in some ethnic groups, and with higher BMI and low physical activity. Further prospective studies are needed to investigate these associations in this population. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Association of body shape phenotypes and body fat distribution indexes with inflammatory biomarkers in the European Prospective Investigation into Cancer and Nutrition (EPIC) and UK Biobank.
- Author
-
González-Gil, Esther M., Peruchet-Noray, Laia, Sedlmeier, Anja M., Christakoudi, Sofia, Biessy, Carine, Navionis, Anne-Sophie, Mahamat-Saleh, Yahya, Jaafar, Rola F., Baurecht, Hansjörg, Guevara, Marcela, Etxezarreta, Pilar Amiano, Verschuren, W. M. Monique, Boer, Jolanda M. A., Olsen, Anja, Tjønneland, Anne, Simeon, Vittorio, Castro-Espin, Carlota, Aune, Dagfinn, Heath, Alicia K., and Gunter, Marc
- Subjects
WAIST-hip ratio ,BODY size ,INTERFERON gamma ,BODY mass index ,C-reactive protein - Abstract
Background: The allometric body shape index (ABSI) and hip index (HI), as well as multi-trait body shape phenotypes, have not yet been compared in their associations with inflammatory markers. The aim of this study was to examine the relationship between novel and traditional anthropometric indexes with inflammation using data from the European Prospective Investigation into Cancer and Nutrition (EPIC) and UK Biobank cohorts. Methods: Participants from EPIC (n = 17,943, 69.1% women) and UK Biobank (n = 426,223, 53.2% women) with data on anthropometric indexes and C-reactive protein (CRP) were included in this cross-sectional analysis. A subset of women in EPIC also had at least one measurement for interleukins, tumour necrosis factor alpha, interferon gamma, leptin, and adiponectin. Four distinct body shape phenotypes were derived by a principal component (PC) analysis on height, weight, body mass index (BMI), waist (WC) and hip circumferences (HC), and waist-to-hip ratio (WHR). PC1 described overall adiposity, PC2 tall with low WHR, PC3 tall and centrally obese, and PC4 high BMI and weight with low WC and HC, suggesting an athletic phenotype. ABSI, HI, waist-to-height ratio and waist-to-hip index (WHI) were also calculated. Linear regression models were carried out separately in EPIC and UK Biobank stratified by sex and adjusted for age, smoking status, education, and physical activity. Results were additionally combined in a random-effects meta-analysis. Results: Traditional anthropometric indexes, particularly BMI, WC, and weight were positively associated with CRP levels, in men and women. Body shape phenotypes also showed distinct associations with CRP. Specifically, PC2 showed inverse associations with CRP in EPIC and UK Biobank in both sexes, similarly to height. PC3 was inversely associated with CRP among women, whereas positive associations were observed among men. Conclusions: Specific indexes of body size and body fat distribution showed differential associations with inflammation in adults. Notably, our results suggest that in women, height may mitigate the impact of a higher WC and HC on inflammation. This suggests that subtypes of adiposity exhibit substantial variation in their inflammatory potential, which may have implications for inflammation-related chronic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Post‐diagnosis physical activity and sedentary behaviour and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta‐analysis.
- Author
-
Markozannes, Georgios, Becerra‐Tomás, Nerea, Cariolou, Margarita, Balducci, Katia, Vieira, Rita, Kiss, Sonia, Aune, Dagfinn, Greenwood, Darren C., Gunter, Marc J., Copson, Ellen, Renehan, Andrew G., Bours, Martijn, Demark‐Wahnefried, Wendy, Hudson, Melissa M., May, Anne M., Odedina, Folakemi T., Skinner, Roderick, Steindorf, Karen, Tjønneland, Anne, and Velikova, Galina
- Subjects
SEDENTARY behavior ,PHYSICAL activity ,COLORECTAL cancer ,CANCER prognosis ,CANCER relapse ,CANCER of unknown primary origin - Abstract
Low physical activity and high sedentary behaviour have been clearly linked with colorectal cancer development, yet data on their potential role in colorectal cancer survival is limited. Better characterisation of these relationships is needed for the development of post‐diagnosis physical activity and sedentary behaviour guidance for colorectal cancer survivors. We searched PubMed and Embase through 28 February 2022 for studies assessing post‐diagnosis physical activity, and/or sedentary behaviour in relation to all‐cause and cause‐specific mortality and recurrence after colorectal cancer diagnosis. Total and recreational physical activity were assessed overall and by frequency, duration, intensity, and volume using categorical, linear, and non‐linear dose–response random‐effects meta‐analyses. The Global Cancer Update Programme (CUP Global) independent Expert Committee on Cancer Survivorship and Expert Panel interpreted and graded the likelihood of causality. We identified 16 observational studies on 82,220 non‐overlapping patients from six countries. Physical activity was consistently inversely associated with colorectal cancer morbidity and mortality outcomes, with 13%–60% estimated reductions in risk. Sedentary behaviour was positively associated with all‐cause mortality. The evidence had methodological limitations including potential confounding, selection bias and reverse causation, coupled with a limited number of studies for most associations. The CUP Global Expert panel concluded limited‐suggestive evidence for recreational physical activity with all‐cause mortality and cancer recurrence. Total physical activity and its specific domains and dimensions, and sedentary behaviour were all graded as limited‐no conclusion for all outcomes. Future research should focus on randomised trials, while observational studies should obtain objective and repeated physical activity measures and better adjustment for confounders. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Post‐diagnosis adiposity, physical activity, sedentary behaviour, dietary factors, supplement use and colorectal cancer prognosis: Global Cancer Update Programme (CUP Global) summary of evidence grading.
- Author
-
Tsilidis, Konstantinos K., Markozannes, Georgios, Becerra‐Tomás, Nerea, Cariolou, Margarita, Balducci, Katia, Vieira, Rita, Kiss, Sonia, Aune, Dagfinn, Greenwood, Darren C., Dossus, Laure, González‐Gil, Esther M., Gunter, Marc J., Allen, Kate, Brockton, Nigel T., Croker, Helen, Gordon‐Dseagu, Vanessa L., Mitrou, Panagiota, Musuwo, Nicole, Wiseman, Martin J., and Copson, Ellen
- Subjects
SEDENTARY behavior ,SOFT drinks ,COLORECTAL cancer ,PHYSICAL activity ,CANCER prognosis ,DIETARY patterns ,CANCER of unknown primary origin - Abstract
Based on the World Cancer Research Fund Global Cancer Update Programme, we performed systematic reviews and meta‐analyses to investigate the association of post‐diagnosis adiposity, physical activity, sedentary behaviour, and dietary factors with colorectal cancer prognosis. We searched PubMed and Embase until 28th February, 2022. An independent expert committee and expert panel graded the quality of evidence. A total of 167 unique publications were reviewed, and all but five were observational studies. The quality of the evidence was graded conservatively due to the high risk of several biases. There was evidence of non‐linearity in the associations between body mass index and colorectal cancer prognosis. The associations appeared reverse J‐shaped, and the quality of this evidence was graded as limited (likelihood of causality: limited‐no conclusion). The evidence on recreational physical activity and lower risk of all‐cause mortality (relative risk [RR] highest vs. lowest: 0.69, 95% confidence interval [CI]: 0.62–0.77) and recurrence/disease‐free survival (RR: 0.80, 95% CI: 0.70–0.92) was graded as limited‐suggestive. There was limited‐suggestive evidence for the associations between healthy dietary and/or lifestyle patterns (including diets that comprised plant‐based foods), intake of whole grains and coffee with lower risk of all‐cause mortality, and between unhealthy dietary patterns and intake of sugary drinks with higher risk of all‐cause mortality. The evidence for other exposures on colorectal cancer outcomes was sparse and graded as limited‐no conclusion. Analyses were conducted excluding cancer patients with metastases without substantial changes in the findings. Well‐designed intervention and cohort studies are needed to support the development of lifestyle recommendations for colorectal cancer patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Post‐diagnosis adiposity and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta‐analysis.
- Author
-
Becerra‐Tomás, Nerea, Markozannes, Georgios, Cariolou, Margarita, Balducci, Katia, Vieira, Rita, Kiss, Sonia, Aune, Dagfinn, Greenwood, Darren C., Dossus, Laure, Copson, Ellen, Renehan, Andrew G., Bours, Martijn, Demark‐Wahnefried, Wendy, Hudson, Melissa M., May, Anne M., Odedina, Folakemi T., Skinner, Roderick, Steindorf, Karen, Tjønneland, Anne, and Velikova, Galina
- Subjects
COLORECTAL cancer ,CANCER prognosis ,CANCER of unknown primary origin ,OBESITY ,WAIST-hip ratio ,CANCER relapse ,CLINICAL trials - Abstract
The adiposity influence on colorectal cancer prognosis remains poorly characterised. We performed a systematic review and meta‐analysis on post‐diagnosis adiposity measures (body mass index [BMI], waist circumference, waist‐to‐hip ratio, weight) or their changes and colorectal cancer outcomes. PubMed and Embase were searched through 28 February 2022. Random‐effects meta‐analyses were conducted when at least three studies had sufficient information. The quality of evidence was interpreted and graded by the Global Cancer Update Programme (CUP Global) independent Expert Committee on Cancer Survivorship and Expert Panel. We reviewed 124 observational studies (85 publications). Meta‐analyses were possible for BMI and all‐cause mortality, colorectal cancer‐specific mortality, and cancer recurrence/disease‐free survival. Non‐linear meta‐analysis indicated a reverse J‐shaped association between BMI and colorectal cancer outcomes (nadir at BMI 28 kg/m2). The highest risk, relative to the nadir, was observed at both ends of the BMI distribution (18 and 38 kg/m2), namely 60% and 23% higher risk for all‐cause mortality; 95% and 26% for colorectal cancer‐specific mortality; and 37% and 24% for cancer recurrence/disease‐free survival, respectively. The higher risk with low BMI was attenuated in secondary analyses of RCTs (compared to cohort studies), among studies with longer follow‐up, and in women suggesting potential methodological limitations and/or altered physiological state. Descriptively synthesised studies on other adiposity‐outcome associations of interest were limited in number and methodological quality. All the associations were graded as limited (likelihood of causality: no conclusion) due to potential methodological limitations (reverse causation, confounding, selection bias). Additional well‐designed observational studies and interventional trials are needed to provide further clarification. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Post‐diagnosis dietary factors, supplement use and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta‐analysis.
- Author
-
Chan, Doris S. M., Cariolou, Margarita, Markozannes, Georgios, Balducci, Katia, Vieira, Rita, Kiss, Sonia, Becerra‐Tomás, Nerea, Aune, Dagfinn, Greenwood, Darren C., González‐Gil, Esther M., Copson, Ellen, Renehan, Andrew G., Bours, Martijn, Demark‐Wahnefried, Wendy, Hudson, Melissa M., May, Anne M., Odedina, Folakemi T., Skinner, Roderick, Steindorf, Karen, and Tjønneland, Anne
- Subjects
COLORECTAL cancer ,CANCER prognosis ,DIETARY patterns ,PEANUT allergy ,CANCER of unknown primary origin ,OMEGA-3 fatty acids ,UNSATURATED fatty acids - Abstract
The role of diet in colorectal cancer prognosis is not well understood and specific lifestyle recommendations are lacking. We searched for randomised controlled trials (RCTs) and longitudinal observational studies on post‐diagnosis dietary factors, supplement use and colorectal cancer survival outcomes in PubMed and Embase from inception until 28th February 2022. Random‐effects dose–response meta‐analyses were conducted when at least three studies had sufficient information. The evidence was interpreted and graded by the CUP Global independent Expert Committee on Cancer Survivorship and Expert Panel. Five RCTs and 35 observational studies were included (30,242 cases, over 8700 all‐cause and 2100 colorectal cancer deaths, 3700 progression, recurrence, or disease‐free events). Meta‐analyses, including 3–10 observational studies each, were conducted for: whole grains, nuts/peanuts, red and processed meat, dairy products, sugary drinks, artificially sweetened beverages, coffee, alcohol, dietary glycaemic load/index, insulin load/index, marine omega‐3 polyunsaturated fatty acids, supplemental calcium, circulating 25‐hydroxyvitamin D (25[OH]D) and all‐cause mortality; for alcohol, supplemental calcium, circulating 25(OH)D and colorectal cancer‐specific mortality; and for circulating 25(OH)D and recurrence/disease‐free survival. The overall evidence was graded as 'limited'. The inverse associations between healthy dietary and/or lifestyle patterns (including diets that comprised plant‐based foods), whole grains, total, caffeinated, or decaffeinated coffee and all‐cause mortality and the positive associations between unhealthy dietary patterns, sugary drinks and all‐cause mortality provided 'limited—suggestive' evidence. All other exposure‐outcome associations provided 'limited—no conclusion' evidence. Additional, well‐conducted cohort studies and carefully designed RCTs are needed to develop specific lifestyle recommendations for colorectal cancer survivors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Leisure-time and occupational physical activity and risk of cardiovascular disease incidence: a systematic-review and dose-response meta-analysis of prospective cohort studies
- Author
-
Kazemi, Asma, primary, Soltani, Sepideh, additional, Aune, Dagfinn, additional, Hosseini, Elham, additional, Mokhtari, Zeinab, additional, Hassanzadeh, Zahra, additional, Jayedi, Ahmad, additional, Pitanga, Francisco, additional, and Akhlaghi, Masoumeh, additional
- Published
- 2024
- Full Text
- View/download PDF
12. Hepatic steatosis, metabolic dysfunction and risk of mortality : findings from a multinational prospective cohort study
- Author
-
Mayén, Ana-Lucia, Sabra, Mirna, Aglago, Elom K., Perlemuter, Gabriel, Voican, Cosmin, Ramos, Ines, Debras, Charlotte, Blanco, Jessica, Viallon, Vivian, Ferrari, Pietro, Olsen, Anja, Tjønneland, Anne, Langmann, Fie, Dahm, Christina C., Rothwell, Joseph, Laouali, Nasser, Marques, Chloé, Schulze, Matthias B., Katzke, Verena, Kaaks, Rudolf, Palli, Domenico, Macciotta, Alessandra, Panico, Salvatore, Tumino, Rosario, Agnoli, Claudia, Farràs, Marta, Molina-Montes, Esther, Amiano, Pilar, Chirlaque, María-Dolores, Castilla, Jesús, Werner, Mårten, Bodén, Stina, Heath, Alicia K., Tsilidis, Kostas, Aune, Dagfinn, Weiderpass, Elisabete, Freisling, Heinz, Gunter, Marc J., Jenab, Mazda, Mayén, Ana-Lucia, Sabra, Mirna, Aglago, Elom K., Perlemuter, Gabriel, Voican, Cosmin, Ramos, Ines, Debras, Charlotte, Blanco, Jessica, Viallon, Vivian, Ferrari, Pietro, Olsen, Anja, Tjønneland, Anne, Langmann, Fie, Dahm, Christina C., Rothwell, Joseph, Laouali, Nasser, Marques, Chloé, Schulze, Matthias B., Katzke, Verena, Kaaks, Rudolf, Palli, Domenico, Macciotta, Alessandra, Panico, Salvatore, Tumino, Rosario, Agnoli, Claudia, Farràs, Marta, Molina-Montes, Esther, Amiano, Pilar, Chirlaque, María-Dolores, Castilla, Jesús, Werner, Mårten, Bodén, Stina, Heath, Alicia K., Tsilidis, Kostas, Aune, Dagfinn, Weiderpass, Elisabete, Freisling, Heinz, Gunter, Marc J., and Jenab, Mazda
- Abstract
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MetS) are implicated in the aetiology of non-communicable diseases. Our study aimed to evaluate associations between NAFLD and MetS with overall and cause-specific mortality. METHODS: We used dietary, lifestyle, anthropometric and metabolic biomarker data from a random subsample of 15,784 EPIC cohort participants. NAFLD was assessed using the fatty liver index (FLI) and MetS using the revised definition. Indices for metabolic dysfunction-associated fatty liver disease (MAFLD) were calculated. The individual associations of these indices with overall and cause-specific mortality were assessed using multivariable Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (95%CIs). As a subobjective, risk associations with adaptations of new classifications of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic and alcohol-related liver disease (MetALD) were also assessed. RESULTS: Among the 15,784 sub-cohort participants, a total of 1997 deaths occurred (835 due to cancer, 520 to CVD, 642 to other causes) over a median 15.6 (IQR, 12.3-17.1) years of follow-up. Compared to an FLI < 30, FLI ≥ 60 was associated with increased risks of overall mortality (HR = 1.44, 95%CI = 1.27-1.63), and deaths from cancer (HR = 1.32, 95%CI = 1.09-1.60), CVD (HR = 2.06, 95% CI = 1.61-2.63) or other causes (HR = 1.21, 95%CI = 0.97-1.51). Mortality risk associations were also elevated for individuals with MAFLD compared to those without. Individuals with MetS were at increased risk of all mortality endpoints, except cancer-specific mortality. MASLD and MetALD were associated with higher risk of overall mortality. CONCLUSIONS: Our findings based on a prospective cohort suggest that individuals with hepatic steatosis or metabolic dysfunction have a higher overall and cause-specific mortality risk.
- Published
- 2024
- Full Text
- View/download PDF
13. Circulating free insulin-like growth factor-I and prostate cancer : a case-control study nested in the European prospective investigation into cancer and nutrition
- Author
-
Cheng, Tuck Seng, Noor, Urwah, Watts, Eleanor, Pollak, Michael, Wang, Ye, McKay, James, Atkins, Joshua, Masala, Giovanna, Sánchez, Maria-Jose, Agudo, Antonio, Castilla, Jesús, Aune, Dagfinn, Colorado-Yohar, Sandra M., Manfredi, Luca, Gunter, Marc J., Pala, Valeria, Josefsson, Andreas, Key, Timothy J., Smith-Byrne, Karl, Travis, Ruth C., Cheng, Tuck Seng, Noor, Urwah, Watts, Eleanor, Pollak, Michael, Wang, Ye, McKay, James, Atkins, Joshua, Masala, Giovanna, Sánchez, Maria-Jose, Agudo, Antonio, Castilla, Jesús, Aune, Dagfinn, Colorado-Yohar, Sandra M., Manfredi, Luca, Gunter, Marc J., Pala, Valeria, Josefsson, Andreas, Key, Timothy J., Smith-Byrne, Karl, and Travis, Ruth C.
- Abstract
BACKGROUND: Circulating total insulin-like growth factor-I (IGF-I) is an established risk factor for prostate cancer. However, only a small proportion of circulating IGF-I is free or readily dissociable from IGF-binding proteins (its bioavailable form), and few studies have investigated the association of circulating free IGF-I with prostate cancer risk. METHODS: We analyzed data from 767 prostate cancer cases and 767 matched controls nested within the European Prospective Investigation into Cancer and Nutrition cohort, with an average of 14-years (interquartile range = 2.9) follow-up. Matching variables were study center, length of follow-up, age, and time of day and fasting duration at blood collection. Circulating free IGF-I concentration was measured in serum samples collected at recruitment visit (mean age 55 years old; standard deviation = 7.1) using an enzyme-linked immunosorbent assay (ELISA). Conditional logistic regressions were performed to examine the associations of free IGF-I with risk of prostate cancer overall and subdivided by time to diagnosis (≤ 14 and > 14 years), and tumor characteristics. RESULTS: Circulating free IGF-I concentrations (in fourths and as a continuous variable) were not associated with prostate cancer risk overall (odds ratio [OR] = 1.00 per 0.1 nmol/L increment, 95% CI: 0.99, 1.02) or by time to diagnosis, or with prostate cancer subtypes, including tumor stage and histological grade. CONCLUSIONS: Estimated circulating free IGF-I was not associated with prostate cancer risk. Further research may consider other assay methods that estimate bioavailable IGF-I to provide more insight into the well-substantiated association between circulating total IGF-I and subsequent prostate cancer risk.
- Published
- 2024
- Full Text
- View/download PDF
14. Plasma concentration of 36 (poly)phenols and prospective body weight change in participants from the EPIC cohort
- Author
-
Gil-Lespinard, Mercedes, Almanza-Aguilera, Enrique, Castañeda, Jazmín, Guiñón-Fort, Daniel, Eriksen, Anne Kirstine, Tjønneland, Anne, Rothwell, Joseph A., Shah, Sanam, Cadeau, Claire, Katzke, Verena, Johnson, Theron, Schulze, Matthias B., Oliverio, Andreina, Pasanisi, Fabrizio, Tumino, Rosario, Manfredi, Luca, Masala, Giovana, Skeie, Guri, Lundblad, Marie Wasmuth, Brustad, Magritt, Lasheras, Cristina, Crous-Bou, Marta, Molina-Montes, Esther, Colorado-Yohar, Sandra, Guevara, Marcela, Amiano, Pilar, Johansson, Ingegerd, Hultdin, Johan, Forouhi, Nita G., Freisling, Heinz, Merdas, Mira, Debras, Charlotte, Heath, Alicia K., Aglago, Elom K., Aune, Dagfinn, Zamora-Ros, Raul, Gil-Lespinard, Mercedes, Almanza-Aguilera, Enrique, Castañeda, Jazmín, Guiñón-Fort, Daniel, Eriksen, Anne Kirstine, Tjønneland, Anne, Rothwell, Joseph A., Shah, Sanam, Cadeau, Claire, Katzke, Verena, Johnson, Theron, Schulze, Matthias B., Oliverio, Andreina, Pasanisi, Fabrizio, Tumino, Rosario, Manfredi, Luca, Masala, Giovana, Skeie, Guri, Lundblad, Marie Wasmuth, Brustad, Magritt, Lasheras, Cristina, Crous-Bou, Marta, Molina-Montes, Esther, Colorado-Yohar, Sandra, Guevara, Marcela, Amiano, Pilar, Johansson, Ingegerd, Hultdin, Johan, Forouhi, Nita G., Freisling, Heinz, Merdas, Mira, Debras, Charlotte, Heath, Alicia K., Aglago, Elom K., Aune, Dagfinn, and Zamora-Ros, Raul
- Abstract
Introduction: Dietary intake of (poly)phenols has been linked to reduced adiposity and body weight (BW) in several epidemiological studies. However, epidemiological evidence on (poly)phenol biomarkers, particularly plasma concentrations, is scarce. We aimed to investigate the associations between plasma (poly)phenols and prospective BW change in participants from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Methods: This study included 761 participants with data on BW at baseline and after 5 years of follow-up. Plasma concentrations of 36 (poly)phenols were measured at baseline using liquid chromatography-tandem mass spectrometry. Associations were assessed through general linear mixed models and multinomial logistic regression models, using change in BW as a continuous or as a categorical variable (BW loss, maintenance, gain), respectively. Plasma (poly)phenols were assessed as log2-transformed continuous variables. The false discovery rate (FDR) was used to control for multiple comparisons. Results: Doubling plasma (poly)phenol concentrations showed a borderline trend towards a positive association with BW loss. Plasma vanillic acid showed the strongest association (−0.53 kg/5 years; 95% confidence interval [CI]: −0.99, −0.07). Similar results were observed for plasma naringenin comparing BW loss versus BW maintenance (odds ratio: 1.1; 95% CI: 1.0, 1.2). These results did not remain significant after FDR correction. Conclusion: Higher concentrations of plasma (poly)phenols suggested a tendency towards 5-year BW maintenance or loss. While certain associations seemed promising, they did not withstand FDR correction, indicating the need for caution in interpreting these results. Further studies using (poly) phenol biomarkers are needed to confirm these suggestive protective trends.
- Published
- 2024
- Full Text
- View/download PDF
15. Post-diagnosis adiposity and colorectal cancer prognosis:A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis
- Author
-
Becerra-Tomás, Nerea, Markozannes, Georgios, Cariolou, Margarita, Balducci, Katia, Vieira, Rita, Kiss, Sonia, Aune, Dagfinn, Greenwood, Darren C., Dossus, Laure, Copson, Ellen, Renehan, Andrew G., Bours, Martijn, Demark-Wahnefried, Wendy, Hudson, Melissa M., May, Anne M., Odedina, Folakemi T., Skinner, Roderick, Steindorf, Karen, Tjønneland, Anne, Velikova, Galina, Baskin, Monica L., Chowdhury, Rajiv, Hill, Lynette, Lewis, Sarah J., Seidell, Jaap, Weijenberg, Matty P., Krebs, John, Cross, Amanda J., Tsilidis, Konstantinos K., Chan, Doris S.M., Becerra-Tomás, Nerea, Markozannes, Georgios, Cariolou, Margarita, Balducci, Katia, Vieira, Rita, Kiss, Sonia, Aune, Dagfinn, Greenwood, Darren C., Dossus, Laure, Copson, Ellen, Renehan, Andrew G., Bours, Martijn, Demark-Wahnefried, Wendy, Hudson, Melissa M., May, Anne M., Odedina, Folakemi T., Skinner, Roderick, Steindorf, Karen, Tjønneland, Anne, Velikova, Galina, Baskin, Monica L., Chowdhury, Rajiv, Hill, Lynette, Lewis, Sarah J., Seidell, Jaap, Weijenberg, Matty P., Krebs, John, Cross, Amanda J., Tsilidis, Konstantinos K., and Chan, Doris S.M.
- Abstract
The adiposity influence on colorectal cancer prognosis remains poorly characterised. We performed a systematic review and meta-analysis on post-diagnosis adiposity measures (body mass index [BMI], waist circumference, waist-to-hip ratio, weight) or their changes and colorectal cancer outcomes. PubMed and Embase were searched through 28 February 2022. Random-effects meta-analyses were conducted when at least three studies had sufficient information. The quality of evidence was interpreted and graded by the Global Cancer Update Programme (CUP Global) independent Expert Committee on Cancer Survivorship and Expert Panel. We reviewed 124 observational studies (85 publications). Meta-analyses were possible for BMI and all-cause mortality, colorectal cancer-specific mortality, and cancer recurrence/disease-free survival. Non-linear meta-analysis indicated a reverse J-shaped association between BMI and colorectal cancer outcomes (nadir at BMI 28 kg/m2). The highest risk, relative to the nadir, was observed at both ends of the BMI distribution (18 and 38 kg/m2), namely 60% and 23% higher risk for all-cause mortality; 95% and 26% for colorectal cancer-specific mortality; and 37% and 24% for cancer recurrence/disease-free survival, respectively. The higher risk with low BMI was attenuated in secondary analyses of RCTs (compared to cohort studies), among studies with longer follow-up, and in women suggesting potential methodological limitations and/or altered physiological state. Descriptively synthesised studies on other adiposity-outcome associations of interest were limited in number and methodological quality. All the associations were graded as limited (likelihood of causality: no conclusion) due to potential methodological limitations (reverse causation, confounding, selection bias). Additional well-designed observational studies and interventional trials are needed to provide further clarification., The adiposity influence on colorectal cancer prognosis remains poorly characterised. We performed a systematic review and meta-analysis on post-diagnosis adiposity measures (body mass index [BMI], waist circumference, waist-to-hip ratio, weight) or their changes and colorectal cancer outcomes. PubMed and Embase were searched through 28 February 2022. Random-effects meta-analyses were conducted when at least three studies had sufficient information. The quality of evidence was interpreted and graded by the Global Cancer Update Programme (CUP Global) independent Expert Committee on Cancer Survivorship and Expert Panel. We reviewed 124 observational studies (85 publications). Meta-analyses were possible for BMI and all-cause mortality, colorectal cancer-specific mortality, and cancer recurrence/disease-free survival. Non-linear meta-analysis indicated a reverse J-shaped association between BMI and colorectal cancer outcomes (nadir at BMI 28 kg/m2). The highest risk, relative to the nadir, was observed at both ends of the BMI distribution (18 and 38 kg/m2), namely 60% and 23% higher risk for all-cause mortality; 95% and 26% for colorectal cancer-specific mortality; and 37% and 24% for cancer recurrence/disease-free survival, respectively. The higher risk with low BMI was attenuated in secondary analyses of RCTs (compared to cohort studies), among studies with longer follow-up, and in women suggesting potential methodological limitations and/or altered physiological state. Descriptively synthesised studies on other adiposity-outcome associations of interest were limited in number and methodological quality. All the associations were graded as limited (likelihood of causality: no conclusion) due to potential methodological limitations (reverse causation, confounding, selection bias). Additional well-designed observational studies and interventional trials are needed to provide further clarification.
- Published
- 2024
16. Post-diagnosis dietary factors, supplement use and colorectal cancer prognosis:A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis
- Author
-
Chan, Doris S.M., Cariolou, Margarita, Markozannes, Georgios, Balducci, Katia, Vieira, Rita, Kiss, Sonia, Becerra-Tomás, Nerea, Aune, Dagfinn, Greenwood, Darren C., González-Gil, Esther M., Copson, Ellen, Renehan, Andrew G., Bours, Martijn, Demark-Wahnefried, Wendy, Hudson, Melissa M., May, Anne M., Odedina, Folakemi T., Skinner, Roderick, Steindorf, Karen, Tjønneland, Anne, Velikova, Galina, Baskin, Monica L., Chowdhury, Rajiv, Hill, Lynette, Lewis, Sarah J., Seidell, Jaap, Weijenberg, Matty P., Krebs, John, Cross, Amanda J., Tsilidis, Konstantinos K., Chan, Doris S.M., Cariolou, Margarita, Markozannes, Georgios, Balducci, Katia, Vieira, Rita, Kiss, Sonia, Becerra-Tomás, Nerea, Aune, Dagfinn, Greenwood, Darren C., González-Gil, Esther M., Copson, Ellen, Renehan, Andrew G., Bours, Martijn, Demark-Wahnefried, Wendy, Hudson, Melissa M., May, Anne M., Odedina, Folakemi T., Skinner, Roderick, Steindorf, Karen, Tjønneland, Anne, Velikova, Galina, Baskin, Monica L., Chowdhury, Rajiv, Hill, Lynette, Lewis, Sarah J., Seidell, Jaap, Weijenberg, Matty P., Krebs, John, Cross, Amanda J., and Tsilidis, Konstantinos K.
- Abstract
The role of diet in colorectal cancer prognosis is not well understood and specific lifestyle recommendations are lacking. We searched for randomised controlled trials (RCTs) and longitudinal observational studies on post-diagnosis dietary factors, supplement use and colorectal cancer survival outcomes in PubMed and Embase from inception until 28th February 2022. Random-effects dose–response meta-analyses were conducted when at least three studies had sufficient information. The evidence was interpreted and graded by the CUP Global independent Expert Committee on Cancer Survivorship and Expert Panel. Five RCTs and 35 observational studies were included (30,242 cases, over 8700 all-cause and 2100 colorectal cancer deaths, 3700 progression, recurrence, or disease-free events). Meta-analyses, including 3–10 observational studies each, were conducted for: whole grains, nuts/peanuts, red and processed meat, dairy products, sugary drinks, artificially sweetened beverages, coffee, alcohol, dietary glycaemic load/index, insulin load/index, marine omega-3 polyunsaturated fatty acids, supplemental calcium, circulating 25-hydroxyvitamin D (25[OH]D) and all-cause mortality; for alcohol, supplemental calcium, circulating 25(OH)D and colorectal cancer-specific mortality; and for circulating 25(OH)D and recurrence/disease-free survival. The overall evidence was graded as ‘limited’. The inverse associations between healthy dietary and/or lifestyle patterns (including diets that comprised plant-based foods), whole grains, total, caffeinated, or decaffeinated coffee and all-cause mortality and the positive associations between unhealthy dietary patterns, sugary drinks and all-cause mortality provided ‘limited—suggestive’ evidence. All other exposure-outcome associations provided ‘limited—no conclusion’ evidence. Additional, well-conducted cohort studies and carefully designed RCTs are needed to develop specific lifestyle recommendations for colorectal cancer survivors., The role of diet in colorectal cancer prognosis is not well understood and specific lifestyle recommendations are lacking. We searched for randomised controlled trials (RCTs) and longitudinal observational studies on post-diagnosis dietary factors, supplement use and colorectal cancer survival outcomes in PubMed and Embase from inception until 28th February 2022. Random-effects dose–response meta-analyses were conducted when at least three studies had sufficient information. The evidence was interpreted and graded by the CUP Global independent Expert Committee on Cancer Survivorship and Expert Panel. Five RCTs and 35 observational studies were included (30,242 cases, over 8700 all-cause and 2100 colorectal cancer deaths, 3700 progression, recurrence, or disease-free events). Meta-analyses, including 3–10 observational studies each, were conducted for: whole grains, nuts/peanuts, red and processed meat, dairy products, sugary drinks, artificially sweetened beverages, coffee, alcohol, dietary glycaemic load/index, insulin load/index, marine omega-3 polyunsaturated fatty acids, supplemental calcium, circulating 25-hydroxyvitamin D (25[OH]D) and all-cause mortality; for alcohol, supplemental calcium, circulating 25(OH)D and colorectal cancer-specific mortality; and for circulating 25(OH)D and recurrence/disease-free survival. The overall evidence was graded as ‘limited’. The inverse associations between healthy dietary and/or lifestyle patterns (including diets that comprised plant-based foods), whole grains, total, caffeinated, or decaffeinated coffee and all-cause mortality and the positive associations between unhealthy dietary patterns, sugary drinks and all-cause mortality provided ‘limited—suggestive’ evidence. All other exposure-outcome associations provided ‘limited—no conclusion’ evidence. Additional, well-conducted cohort studies and carefully designed RCTs are needed to develop specific lifestyle recommendations for colorectal cancer survivors.
- Published
- 2024
17. Post-diagnosis physical activity and sedentary behaviour and colorectal cancer prognosis:A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis
- Author
-
Markozannes, Georgios, Becerra-Tomás, Nerea, Cariolou, Margarita, Balducci, Katia, Vieira, Rita, Kiss, Sonia, Aune, Dagfinn, Greenwood, Darren C., Gunter, Marc J., Copson, Ellen, Renehan, Andrew G., Bours, Martijn, Demark-Wahnefried, Wendy, Hudson, Melissa M., May, Anne M., Odedina, Folakemi T., Skinner, Roderick, Steindorf, Karen, Tjønneland, Anne, Velikova, Galina, Baskin, Monica L., Chowdhury, Rajiv, Hill, Lynette, Lewis, Sarah J., Seidell, Jaap, Weijenberg, Matty P., Krebs, John, Cross, Amanda J., Tsilidis, Konstantinos K., Chan, Doris S.M., Markozannes, Georgios, Becerra-Tomás, Nerea, Cariolou, Margarita, Balducci, Katia, Vieira, Rita, Kiss, Sonia, Aune, Dagfinn, Greenwood, Darren C., Gunter, Marc J., Copson, Ellen, Renehan, Andrew G., Bours, Martijn, Demark-Wahnefried, Wendy, Hudson, Melissa M., May, Anne M., Odedina, Folakemi T., Skinner, Roderick, Steindorf, Karen, Tjønneland, Anne, Velikova, Galina, Baskin, Monica L., Chowdhury, Rajiv, Hill, Lynette, Lewis, Sarah J., Seidell, Jaap, Weijenberg, Matty P., Krebs, John, Cross, Amanda J., Tsilidis, Konstantinos K., and Chan, Doris S.M.
- Abstract
Low physical activity and high sedentary behaviour have been clearly linked with colorectal cancer development, yet data on their potential role in colorectal cancer survival is limited. Better characterisation of these relationships is needed for the development of post-diagnosis physical activity and sedentary behaviour guidance for colorectal cancer survivors. We searched PubMed and Embase through 28 February 2022 for studies assessing post-diagnosis physical activity, and/or sedentary behaviour in relation to all-cause and cause-specific mortality and recurrence after colorectal cancer diagnosis. Total and recreational physical activity were assessed overall and by frequency, duration, intensity, and volume using categorical, linear, and non-linear dose–response random-effects meta-analyses. The Global Cancer Update Programme (CUP Global) independent Expert Committee on Cancer Survivorship and Expert Panel interpreted and graded the likelihood of causality. We identified 16 observational studies on 82,220 non-overlapping patients from six countries. Physical activity was consistently inversely associated with colorectal cancer morbidity and mortality outcomes, with 13%–60% estimated reductions in risk. Sedentary behaviour was positively associated with all-cause mortality. The evidence had methodological limitations including potential confounding, selection bias and reverse causation, coupled with a limited number of studies for most associations. The CUP Global Expert panel concluded limited-suggestive evidence for recreational physical activity with all-cause mortality and cancer recurrence. Total physical activity and its specific domains and dimensions, and sedentary behaviour were all graded as limited-no conclusion for all outcomes. Future research should focus on randomised trials, while observational studies should obtain objective and repeated physical activity measures and better adjustment for confounders., Low physical activity and high sedentary behaviour have been clearly linked with colorectal cancer development, yet data on their potential role in colorectal cancer survival is limited. Better characterisation of these relationships is needed for the development of post-diagnosis physical activity and sedentary behaviour guidance for colorectal cancer survivors. We searched PubMed and Embase through 28 February 2022 for studies assessing post-diagnosis physical activity, and/or sedentary behaviour in relation to all-cause and cause-specific mortality and recurrence after colorectal cancer diagnosis. Total and recreational physical activity were assessed overall and by frequency, duration, intensity, and volume using categorical, linear, and non-linear dose–response random-effects meta-analyses. The Global Cancer Update Programme (CUP Global) independent Expert Committee on Cancer Survivorship and Expert Panel interpreted and graded the likelihood of causality. We identified 16 observational studies on 82,220 non-overlapping patients from six countries. Physical activity was consistently inversely associated with colorectal cancer morbidity and mortality outcomes, with 13%–60% estimated reductions in risk. Sedentary behaviour was positively associated with all-cause mortality. The evidence had methodological limitations including potential confounding, selection bias and reverse causation, coupled with a limited number of studies for most associations. The CUP Global Expert panel concluded limited-suggestive evidence for recreational physical activity with all-cause mortality and cancer recurrence. Total physical activity and its specific domains and dimensions, and sedentary behaviour were all graded as limited-no conclusion for all outcomes. Future research should focus on randomised trials, while observational studies should obtain objective and repeated physical activity measures and better adjustment for confounders.
- Published
- 2024
18. Post-diagnosis adiposity, physical activity, sedentary behaviour, dietary factors, supplement use and colorectal cancer prognosis:Global Cancer Update Programme (CUP Global) summary of evidence grading
- Author
-
Tsilidis, Konstantinos K., Markozannes, Georgios, Becerra-Tomás, Nerea, Cariolou, Margarita, Balducci, Katia, Vieira, Rita, Kiss, Sonia, Aune, Dagfinn, Greenwood, Darren C., Dossus, Laure, González-Gil, Esther M., Gunter, Marc J., Allen, Kate, Brockton, Nigel T., Croker, Helen, Gordon-Dseagu, Vanessa L., Mitrou, Panagiota, Musuwo, Nicole, Wiseman, Martin J., Copson, Ellen, Renehan, Andrew G., Bours, Martijn, Demark-Wahnefried, Wendy, Hudson, Melissa M., May, Anne M., Odedina, Folakemi T., Skinner, Roderick, Steindorf, Karen, Tjønneland, Anne, Velikova, Galina, Baskin, Monica L., Chowdhury, Rajiv, Hill, Lynette, Lewis, Sarah J., Seidell, Jaap, Weijenberg, Matty P., Krebs, John, Cross, Amanda J., Chan, Doris S.M., Tsilidis, Konstantinos K., Markozannes, Georgios, Becerra-Tomás, Nerea, Cariolou, Margarita, Balducci, Katia, Vieira, Rita, Kiss, Sonia, Aune, Dagfinn, Greenwood, Darren C., Dossus, Laure, González-Gil, Esther M., Gunter, Marc J., Allen, Kate, Brockton, Nigel T., Croker, Helen, Gordon-Dseagu, Vanessa L., Mitrou, Panagiota, Musuwo, Nicole, Wiseman, Martin J., Copson, Ellen, Renehan, Andrew G., Bours, Martijn, Demark-Wahnefried, Wendy, Hudson, Melissa M., May, Anne M., Odedina, Folakemi T., Skinner, Roderick, Steindorf, Karen, Tjønneland, Anne, Velikova, Galina, Baskin, Monica L., Chowdhury, Rajiv, Hill, Lynette, Lewis, Sarah J., Seidell, Jaap, Weijenberg, Matty P., Krebs, John, Cross, Amanda J., and Chan, Doris S.M.
- Abstract
Based on the World Cancer Research Fund Global Cancer Update Programme, we performed systematic reviews and meta-analyses to investigate the association of post-diagnosis adiposity, physical activity, sedentary behaviour, and dietary factors with colorectal cancer prognosis. We searched PubMed and Embase until 28th February, 2022. An independent expert committee and expert panel graded the quality of evidence. A total of 167 unique publications were reviewed, and all but five were observational studies. The quality of the evidence was graded conservatively due to the high risk of several biases. There was evidence of non-linearity in the associations between body mass index and colorectal cancer prognosis. The associations appeared reverse J-shaped, and the quality of this evidence was graded as limited (likelihood of causality: limited-no conclusion). The evidence on recreational physical activity and lower risk of all-cause mortality (relative risk [RR] highest vs. lowest: 0.69, 95% confidence interval [CI]: 0.62–0.77) and recurrence/disease-free survival (RR: 0.80, 95% CI: 0.70–0.92) was graded as limited-suggestive. There was limited-suggestive evidence for the associations between healthy dietary and/or lifestyle patterns (including diets that comprised plant-based foods), intake of whole grains and coffee with lower risk of all-cause mortality, and between unhealthy dietary patterns and intake of sugary drinks with higher risk of all-cause mortality. The evidence for other exposures on colorectal cancer outcomes was sparse and graded as limited-no conclusion. Analyses were conducted excluding cancer patients with metastases without substantial changes in the findings. Well-designed intervention and cohort studies are needed to support the development of lifestyle recommendations for colorectal cancer patients., Based on the World Cancer Research Fund Global Cancer Update Programme, we performed systematic reviews and meta-analyses to investigate the association of post-diagnosis adiposity, physical activity, sedentary behaviour, and dietary factors with colorectal cancer prognosis. We searched PubMed and Embase until 28th February, 2022. An independent expert committee and expert panel graded the quality of evidence. A total of 167 unique publications were reviewed, and all but five were observational studies. The quality of the evidence was graded conservatively due to the high risk of several biases. There was evidence of non-linearity in the associations between body mass index and colorectal cancer prognosis. The associations appeared reverse J-shaped, and the quality of this evidence was graded as limited (likelihood of causality: limited-no conclusion). The evidence on recreational physical activity and lower risk of all-cause mortality (relative risk [RR] highest vs. lowest: 0.69, 95% confidence interval [CI]: 0.62–0.77) and recurrence/disease-free survival (RR: 0.80, 95% CI: 0.70–0.92) was graded as limited-suggestive. There was limited-suggestive evidence for the associations between healthy dietary and/or lifestyle patterns (including diets that comprised plant-based foods), intake of whole grains and coffee with lower risk of all-cause mortality, and between unhealthy dietary patterns and intake of sugary drinks with higher risk of all-cause mortality. The evidence for other exposures on colorectal cancer outcomes was sparse and graded as limited-no conclusion. Analyses were conducted excluding cancer patients with metastases without substantial changes in the findings. Well-designed intervention and cohort studies are needed to support the development of lifestyle recommendations for colorectal cancer patients.
- Published
- 2024
19. Framingham risk scores for determination the 10-year risk of cardiovascular disease in participants with and without the metabolic syndrome: results of the Fasa Persian cohort study.
- Author
-
Dehghan, Azizallah, Jahangiry, Leila, Khezri, Rozhan, Jafari, Alireza, Pezeshki, Babak, Rezaei, Fatemeh, and Aune, Dagfinn
- Subjects
CARDIOVASCULAR disease prevention ,RISK assessment ,CROSS-sectional method ,HIGH density lipoproteins ,CARDIOVASCULAR diseases ,RESEARCH funding ,SEX distribution ,SMOKING ,MULTIPLE regression analysis ,CARDIOVASCULAR diseases risk factors ,AGE distribution ,DESCRIPTIVE statistics ,LONGITUDINAL method ,WAIST circumference ,METABOLIC syndrome ,CHOLESTEROL ,SYSTOLIC blood pressure ,TRIGLYCERIDES ,DIABETES - Abstract
Background: Metabolic syndrome (MetS) is a cluster of risk factors and the Framingham risk score (FRS) is a useful metric for measuring the 10-year cardiovascular disease (CVD) risk of the population. The present study aimed to determine the 10-year risk of cardiovascular disease using the Framingham risk score in people with and without MetS in a large Iranian cohort study. Methods: This cross-sectional study was done using the Fasa cohort. Participants aged ≥ 35 years old were recruited to the study from 2015 to 2016. The FRS was calculated using age, sex, current smoking, diabetes, systolic blood pressure (SBP), total cholesterol, and high-density lipoprotein (HDL) cholesterol. MetS was defined as the presence of three or more of the MetS risk factors including triglyceride (TG) level ≥ 150 mg dl
− 1 , HDL level < 40 mg dl− 1 in men and < 50 mg dl− 1 in women, systolic/diastolic blood pressure ≥ 130/≥85 mmHg or using medicine for hypertension, fasting blood sugar (FBS) level ≥ 100 mg dl− 1 or using diabetes medication and abdominal obesity considered as waist circumference (WC) ≥ 88 cm for women and ≥ 102 cm for men. Multiple logistic regressions were applied to estimate the 10- year CVD risk among people with and without MetS. Results: Of 8949 participants, 1928 people (21.6%) had MetS. The mean age of the participants with and without Mets was 50.4 ± 9.2 years and 46.9 ± 9.1 years respectively. In total 15.3% of participants with MetS and 8.0% of participants without MetS were in the high-risk category of 10-year CVD risk. Among participants with MetS gender, TG, SBP, FBS and in people without MetS gender, TG, SBP, FBS, and HDL showed strong associations with the predicted 10-year CVD risk. Conclusion: Male sex and increased SBP, TG, and FBS parameters were strongly associated with increased 10-year risk of CVD in people with and without MetS. In people without MetS, reduced HDL-cholestrol was strongly associated with increased 10-year risk of CVD. The recognition of participant's TG, blood pressure (BP), FBS and planning appropriate lifestyle interventions related to these characteristics is an important step towards prevention of CVD. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
20. Walking speed and the risk of type 2 diabetes: a systematic review and meta-analysis.
- Author
-
Jayedi, Ahmad, Zargar, Mahdieh-Sadat, Emadi, Alireza, and Aune, Dagfinn
- Published
- 2024
- Full Text
- View/download PDF
21. Blood pressure, hypertension, and the risk of heart failure: a systematic review and meta-analysis of cohort studies.
- Author
-
Baffour, Priscilla Kyei, Jahangiry, Leila, Jain, Shalu, Sen, Abhijit, and Aune, Dagfinn
- Published
- 2024
- Full Text
- View/download PDF
22. International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts.
- Author
-
Timmins, Iain R., Jones, Michael E., O'Brien, Katie M., Adami, Hans-Olov, Aune, Dagfinn, Baglietto, Laura, Bertrand, Kimberly A., Brantley, Kristen D., Chen, Yu, Clague DeHart, Jessica, Clendenen, Tess V., Dossus, Laure, Eliassen, A. Heather, Fletcher, Olivia, Fournier, Agnès, Håkansson, Niclas, Hankinson, Susan E., Houlston, Richard S., Joshu, Corinne E., and Kirsh, Victoria A.
- Published
- 2024
- Full Text
- View/download PDF
23. Temporal trends in mortality of aortic dissection and rupture in the UK, Japan, the USA and Canada.
- Author
-
Makoto Hibino, Verma, Subodh, Jarret, Craig M., Junichi Shimamura, Verma, Raj, Hiromi Hibino, Baeza, Cristian R., Aune, Dagfinn, Yanagawa, Bobby, Usui, Akihiko, Nienaber, Christoph A., and Pelletier, Marc P.
- Subjects
AORTIC dissection ,AORTIC rupture ,DISSECTION ,THORACIC aneurysms ,ABDOMINAL aortic aneurysms ,ENDOVASCULAR aneurysm repair ,DISSECTING aneurysms - Published
- 2024
- Full Text
- View/download PDF
24. Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies.
- Author
-
Die, M Diana van, Bone, Kerry M, Visvanathan, Kala, Kyrø, Cecile, Aune, Dagfinn, Ee, Carolyn, and Paller, Channing J
- Subjects
PHYTONUTRIENTS ,BREAST cancer diagnosis ,DISEASE relapse - Abstract
Background Phytonutrient intakes may improve outcomes following breast cancer, but the impact of postdiagnosis introduction vs established prediagnostic exposure as well as optimum doses has not been established. Evidence from observational studies for key exposures was evaluated, including dosage and intake time frames. Methods MEDLINE, EMBASE, CINAHL, Cochrane Library, ClinicalTrials.gov, and the ISRCTN registry were searched for prospective and retrospective observational studies investigating the impact of soybean, lignans, cruciferous (cabbage-family) vegetables, green tea, or their phytonutrients on breast cancer survival outcomes. A random-effects model was used to calculate summary hazard ratios (HRs) and 95% confidence intervals (CIs). Nonlinear dose-response analyses were conducted using restricted cubic splines. Results Thirty-two articles were included. Soy isoflavones were associated with a 26% reduced risk of recurrence (HR = 0.74, 95% CI = 0.60 to 0.92), particularly among postmenopausal (HR = 0.72, 95% CI = 0.55 to 0.94) and estrogen receptor–positive survivors (HR = 0.82, 95% CI = 0.70 to 0.97), with the greatest risk reduction at 60 mg/day. In mortality outcomes, the reduction was mostly at 20 to 40 mg/day. Soy protein and products were inversely associated with cancer-specific mortality for estrogen receptor–positive disease (HR = 0.75, 95% CI = 0.60 to 0.92). An inverse association was observed for serum or plasma enterolactone, measured prediagnosis and early postdiagnosis, with cancer-specific mortality (HR = 0.72, 95% CI = 0.58 to 0.90) and all-cause mortality (HR = 0.69, 95% CI = 0.57 to 0.83). No effects were observed for cruciferous vegetables. There was a 44% reduced risk of recurrence with prediagnostic green tea for stage I and II breast cancer (HR = 0.56, 95% CI = 0.38 to 0.83). Conclusions Soy, enterolactone, and green tea demonstrated significant risk reductions in outcomes following breast cancer. Evidence is needed regarding the impact of postdiagnostic introduction or substantial increase of these exposures. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Ultra processed foods and cancer—authors' reply
- Author
-
Freisling, Heinz, Córdova, Reynalda, Aune, Dagfinn, and Wagner, Karl-Heinz
- Published
- 2024
- Full Text
- View/download PDF
26. Temporal trends in mortality of aortic dissection and rupture in the UK, Japan, the USA and Canada
- Author
-
Hibino, Makoto, Verma, Subodh, Jarret, Craig M, Shimamura, Junichi, Verma, Raj, Hibino, Hiromi, Baeza, Cristian R, Aune, Dagfinn, Yanagawa, Bobby, Usui, Akihiko, Nienaber, Christoph A, and Pelletier, Marc P
- Abstract
ObjectiveAortic dissection and aortic aneurysm rupture are aortic emergencies and their clinical outcomes have improved over the past two decades; however, whether this has translated into lower mortality across countries remains an open question. The purpose of this study was to compare mortality trends from aortic dissection and rupture between the UK, Japan, the USA and Canada.MethodsWe analysed the WHO mortality database to determine trends in mortality from aortic dissection and rupture in four countries from 2000 to 2019. Age-standardised mortality rates per 100 000 persons were calculated, and annual percentage change was estimated using joinpoint regression.ResultsAge-standardised mortality rates per 100 000 persons from aortic dissection and rupture in 2019 were 1.04 and 1.80 in the UK, 2.66 and 1.16 in Japan, 0.76 and 0.52 in the USA, and 0.67 and 0.81 in Canada, respectively. There was significantly decreasing trends in age-standardised mortality from aortic rupture in all four countries and decreasing trends in age-standardised mortality from aortic dissection in the UK over the study period. There was significantly increasing trends in mortality from aortic dissection in Japan over the study period. Joinpoint regression identified significant changes in the aortic dissection trends from decreasing to increasing in the USA from 2010 and Canada from 2012. In sensitivity analyses stratified by sex, similar trends were observed.ConclusionsTrends in mortality from aortic rupture are decreasing; however, mortality from aortic dissection is increasing in Japan, the USA and Canada. Further study to explain these trends is warranted.
- Published
- 2024
- Full Text
- View/download PDF
27. Meat consumption and type 2 diabetes
- Author
-
Aune, Dagfinn
- Published
- 2024
- Full Text
- View/download PDF
28. The association between body mass index and vulvar and vaginal cancer incidence: findings from a large Norwegian cohort study.
- Author
-
Aune D, Nordsletten M, Myklebust TÅ, Robsahm TE, Skålhegg BS, Mala T, Yaqub S, and Saeed U
- Abstract
Background: There is limited evidence of potential associations between body mass index (BMI) and risk of vulvar and vaginal cancer. We explored these associations in a large cohort of Norwegian women., Methods: The analytical dataset included 889,441 women aged 16-75 years at baseline in 1963-1975. Multivariable Cox regression analyses were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the associations between BMI and vulvar and vaginal cancer incidence., Results: During 30.1 million person-years of follow-up, 1748 incident vulvar and 408 incident vaginal cancer cases occurred. The HRs (95% CIs) for vulvar cancer for a BMI of 15- < 18.5, 18.5- < 25, 25- < 30, 30- < 35, ≥ 35 were 0.62 (0.38-1.01), 1.00 (reference), 1.23 (1.10-1.40), 1.43 (1.23-1.66) and 1.72 (1.35-2.20, p
trend < 0.001), and per 5 kg/m2 increment was 1.20 (1.13-1.26). The corresponding HRs (95% CIs) for vaginal cancer were 1.05 (0.52-2.15), 1.00, 0.89 (0.71-1.12), 0.95 (0.68-1.34), and 2.01 (1.29-3.13, ptrend < 0.001), respectively, and per 5 kg/m2 was 1.11 (0.99-1.25). The HR (95% CI) per 5 kg/m2 increase in BMI at ages 16-29 was 1.28 (1.07-1.54, n = 250 cases) for vulvar and 1.53 (1.11-2.11, n = 66 cases) for vaginal cancers. The HR (95% CI) per 5 kg/m2 for early-onset (< 50 years age at diagnosis) vulvar cancer was 0.92 (0.66-1.28, n = 87 cases) and 1.70 (1.05-2.76, n = 21 cases) for vaginal cancer., Conclusion: These results further support the associations between higher BMI and increased risk of vulvar and vaginal cancers, with suggestive stronger associations between BMI in early adulthood for both cancers and for early-onset vaginal cancer. Further studies are needed to elucidate these findings and investigate the underlying mechanisms., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
29. Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study.
- Author
-
Cariolou M, Christakoudi S, Gunter MJ, Key T, Pérez-Cornago A, Travis R, Zamora-Ros R, Petersen KET, Tjønneland A, Weiderpass E, Kaaks R, Seibold P, Inan-Eroglu E, Schulze MB, Masala G, Agnoli C, Tumino R, Di Girolamo C, Aizpurua A, Rodriguez-Barranco M, Santiuste C, Guevara M, Aune D, Chan DSM, Muller DC, and Tsilidis KK
- Subjects
- Humans, Male, Middle Aged, Prognosis, Prospective Studies, Risk Factors, Aged, Obesity complications, Europe epidemiology, Cause of Death, Prostatic Neoplasms mortality, Prostatic Neoplasms diagnosis, Prostatic Neoplasms pathology, Body Mass Index, Adiposity, Waist Circumference, Proportional Hazards Models, Waist-Hip Ratio
- Abstract
Background: Adiposity has been characterized as a modifiable risk factor for prostate cancer. Its association with outcomes after prostate cancer diagnosis, however, must be better understood, and more evidence is needed to facilitate the development of lifestyle guidance for patients with prostate cancer., Methods: We investigated the associations between adiposity indices close to prostate cancer diagnosis (up to 2 years before or up to 5 years after diagnosis) and mortality in 1968 men of the European Prospective Investigation into Cancer and Nutrition cohort. Men were followed up for a median of 9.5 years. Cox proportional hazards models were adjusted for age and year of diagnosis, disease stage and grade, and smoking history and stratified by country., Results: Each 5-unit increment in prediagnosis or postdiagnosis body mass index combined was associated with a 30% higher rate of all-cause mortality and a 49% higher rate of prostate cancer-specific mortality. Similarly, each 5-unit increment in prediagnosis body mass index was associated with a 35% higher rate of all-cause mortality and a 51% higher rate of prostate cancer-specific mortality. The associations were less strong for postdiagnosis body mass index, with a lower number of men in analyses. Less clear positive associations were shown for waist circumference, hip circumference, and waist to hip ratio, but data were limited., Conclusions: Elevated levels of adiposity close to prostate cancer diagnosis could lead to higher risk of mortality; therefore, men are encouraged to maintain a healthy weight. Additional research is needed to confirm whether excessive adiposity after prostate cancer diagnosis could worsen prognosis., (© The Author(s) 2024. Published by Oxford University Press.)
- Published
- 2024
- Full Text
- View/download PDF
30. Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study.
- Author
-
Mayén AL, Sabra M, Aglago EK, Perlemuter G, Voican C, Ramos I, Debras C, Blanco J, Viallon V, Ferrari P, Olsen A, Tjønneland A, Langmann F, Dahm CC, Rothwell J, Laouali N, Marques C, Schulze MB, Katzke V, Kaaks R, Palli D, Macciotta A, Panico S, Tumino R, Agnoli C, Farràs M, Molina-Montes E, Amiano P, Chirlaque MD, Castilla J, Werner M, Bodén S, Heath AK, Tsilidis K, Aune D, Weiderpass E, Freisling H, Gunter MJ, and Jenab M
- Subjects
- Humans, Male, Female, Middle Aged, Prospective Studies, Adult, Aged, Risk Factors, Cohort Studies, Fatty Liver mortality, Metabolic Syndrome mortality, Non-alcoholic Fatty Liver Disease mortality
- Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MetS) are implicated in the aetiology of non-communicable diseases. Our study aimed to evaluate associations between NAFLD and MetS with overall and cause-specific mortality., Methods: We used dietary, lifestyle, anthropometric and metabolic biomarker data from a random subsample of 15,784 EPIC cohort participants. NAFLD was assessed using the fatty liver index (FLI) and MetS using the revised definition. Indices for metabolic dysfunction-associated fatty liver disease (MAFLD) were calculated. The individual associations of these indices with overall and cause-specific mortality were assessed using multivariable Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (95%CIs). As a subobjective, risk associations with adaptations of new classifications of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic and alcohol-related liver disease (MetALD) were also assessed., Results: Among the 15,784 sub-cohort participants, a total of 1997 deaths occurred (835 due to cancer, 520 to CVD, 642 to other causes) over a median 15.6 (IQR, 12.3-17.1) years of follow-up. Compared to an FLI < 30, FLI ≥ 60 was associated with increased risks of overall mortality (HR = 1.44, 95%CI = 1.27-1.63), and deaths from cancer (HR = 1.32, 95%CI = 1.09-1.60), CVD (HR = 2.06, 95% CI = 1.61-2.63) or other causes (HR = 1.21, 95%CI = 0.97-1.51). Mortality risk associations were also elevated for individuals with MAFLD compared to those without. Individuals with MetS were at increased risk of all mortality endpoints, except cancer-specific mortality. MASLD and MetALD were associated with higher risk of overall mortality., Conclusions: Our findings based on a prospective cohort suggest that individuals with hepatic steatosis or metabolic dysfunction have a higher overall and cause-specific mortality risk., (© 2024. World Health Organization.)
- Published
- 2024
- Full Text
- View/download PDF
31. Circulating free insulin-like growth factor-I and prostate cancer: a case-control study nested in the European prospective investigation into cancer and nutrition.
- Author
-
Cheng TS, Noor U, Watts E, Pollak M, Wang Y, McKay J, Atkins J, Masala G, Sánchez MJ, Agudo A, Castilla J, Aune D, Colorado-Yohar SM, Manfredi L, Gunter MJ, Pala V, Josefsson A, Key TJ, Smith-Byrne K, and Travis RC
- Subjects
- Humans, Male, Middle Aged, Case-Control Studies, Prospective Studies, Europe epidemiology, Aged, Risk Factors, Biomarkers, Tumor blood, Insulin-Like Peptides, Prostatic Neoplasms blood, Prostatic Neoplasms epidemiology, Prostatic Neoplasms pathology, Insulin-Like Growth Factor I metabolism, Insulin-Like Growth Factor I analysis
- Abstract
Background: Circulating total insulin-like growth factor-I (IGF-I) is an established risk factor for prostate cancer. However, only a small proportion of circulating IGF-I is free or readily dissociable from IGF-binding proteins (its bioavailable form), and few studies have investigated the association of circulating free IGF-I with prostate cancer risk., Methods: We analyzed data from 767 prostate cancer cases and 767 matched controls nested within the European Prospective Investigation into Cancer and Nutrition cohort, with an average of 14-years (interquartile range = 2.9) follow-up. Matching variables were study center, length of follow-up, age, and time of day and fasting duration at blood collection. Circulating free IGF-I concentration was measured in serum samples collected at recruitment visit (mean age 55 years old; standard deviation = 7.1) using an enzyme-linked immunosorbent assay (ELISA). Conditional logistic regressions were performed to examine the associations of free IGF-I with risk of prostate cancer overall and subdivided by time to diagnosis (≤ 14 and > 14 years), and tumor characteristics., Results: Circulating free IGF-I concentrations (in fourths and as a continuous variable) were not associated with prostate cancer risk overall (odds ratio [OR] = 1.00 per 0.1 nmol/L increment, 95% CI: 0.99, 1.02) or by time to diagnosis, or with prostate cancer subtypes, including tumor stage and histological grade., Conclusions: Estimated circulating free IGF-I was not associated with prostate cancer risk. Further research may consider other assay methods that estimate bioavailable IGF-I to provide more insight into the well-substantiated association between circulating total IGF-I and subsequent prostate cancer risk., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
32. Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies.
- Author
-
van Die MD, Bone KM, Visvanathan K, Kyrø C, Aune D, Ee C, and Paller CJ
- Subjects
- Humans, Female, Prospective Studies, Retrospective Studies, Receptors, Estrogen, Tea, Breast Neoplasms
- Abstract
Background: Phytonutrient intakes may improve outcomes following breast cancer, but the impact of postdiagnosis introduction vs established prediagnostic exposure as well as optimum doses has not been established. Evidence from observational studies for key exposures was evaluated, including dosage and intake time frames., Methods: MEDLINE, EMBASE, CINAHL, Cochrane Library, ClinicalTrials.gov, and the ISRCTN registry were searched for prospective and retrospective observational studies investigating the impact of soybean, lignans, cruciferous (cabbage-family) vegetables, green tea, or their phytonutrients on breast cancer survival outcomes. A random-effects model was used to calculate summary hazard ratios (HRs) and 95% confidence intervals (CIs). Nonlinear dose-response analyses were conducted using restricted cubic splines., Results: Thirty-two articles were included. Soy isoflavones were associated with a 26% reduced risk of recurrence (HR = 0.74, 95% CI = 0.60 to 0.92), particularly among postmenopausal (HR = 0.72, 95% CI = 0.55 to 0.94) and estrogen receptor-positive survivors (HR = 0.82, 95% CI = 0.70 to 0.97), with the greatest risk reduction at 60 mg/day. In mortality outcomes, the reduction was mostly at 20 to 40 mg/day. Soy protein and products were inversely associated with cancer-specific mortality for estrogen receptor-positive disease (HR = 0.75, 95% CI = 0.60 to 0.92). An inverse association was observed for serum or plasma enterolactone, measured prediagnosis and early postdiagnosis, with cancer-specific mortality (HR = 0.72, 95% CI = 0.58 to 0.90) and all-cause mortality (HR = 0.69, 95% CI = 0.57 to 0.83). No effects were observed for cruciferous vegetables. There was a 44% reduced risk of recurrence with prediagnostic green tea for stage I and II breast cancer (HR = 0.56, 95% CI = 0.38 to 0.83)., Conclusions: Soy, enterolactone, and green tea demonstrated significant risk reductions in outcomes following breast cancer. Evidence is needed regarding the impact of postdiagnostic introduction or substantial increase of these exposures., (© The Author(s) 2023. Published by Oxford University Press.)
- Published
- 2024
- Full Text
- View/download PDF
33. Plasma Concentration of 36 (Poly)phenols and Prospective Body Weight Change in Participants from the EPIC Cohort.
- Author
-
Gil-Lespinard M, Almanza-Aguilera E, Castañeda J, Guiñón-Fort D, Eriksen AK, Tjønneland A, Rothwell JA, Shah S, Cadeau C, Katzke V, Johnson T, Schulze MB, Oliverio A, Pasanisi F, Tumino R, Manfredi L, Masala G, Skeie G, Lundblad MW, Brustad M, Lasheras C, Crous-Bou M, Molina-Montes E, Colorado-Yohar S, Guevara M, Amiano P, Johansson I, Hultdin J, Forouhi NG, Freisling H, Merdas M, Debras C, Heath AK, Aglago EK, Aune D, and Zamora-Ros R
- Subjects
- Humans, Prospective Studies, Phenol, Body Weight, Biomarkers, Phenols, Neoplasms
- Abstract
Introduction: Dietary intake of (poly)phenols has been linked to reduced adiposity and body weight (BW) in several epidemiological studies. However, epidemiological evidence on (poly)phenol biomarkers, particularly plasma concentrations, is scarce. We aimed to investigate the associations between plasma (poly)phenols and prospective BW change in participants from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort., Methods: This study included 761 participants with data on BW at baseline and after 5 years of follow-up. Plasma concentrations of 36 (poly)phenols were measured at baseline using liquid chromatography-tandem mass spectrometry. Associations were assessed through general linear mixed models and multinomial logistic regression models, using change in BW as a continuous or as a categorical variable (BW loss, maintenance, gain), respectively. Plasma (poly)phenols were assessed as log2-transformed continuous variables. The false discovery rate (FDR) was used to control for multiple comparisons., Results: Doubling plasma (poly)phenol concentrations showed a borderline trend towards a positive association with BW loss. Plasma vanillic acid showed the strongest association (-0.53 kg/5 years; 95% confidence interval [CI]: -0.99, -0.07). Similar results were observed for plasma naringenin comparing BW loss versus BW maintenance (odds ratio: 1.1; 95% CI: 1.0, 1.2). These results did not remain significant after FDR correction., Conclusion: Higher concentrations of plasma (poly)phenols suggested a tendency towards 5-year BW maintenance or loss. While certain associations seemed promising, they did not withstand FDR correction, indicating the need for caution in interpreting these results. Further studies using (poly)phenol biomarkers are needed to confirm these suggestive protective trends., (© 2024 The Author(s). Published by S. Karger AG, Basel.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.